Man Group’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-15,586
Closed -$506K 2218
2023
Q2
$506K Buy
+15,586
New +$569K ﹤0.01% 1583
2023
Q1
Hold
0
1518
2022
Q2
Sell
-13,321
Closed -$550K 2468
2022
Q1
$550K Buy
+13,321
New +$469K ﹤0.01% 1556
2021
Q2
Sell
-69,310
Closed -$3.51M 2122
2021
Q1
$3.51M Buy
69,310
+25,694
+59% +$1.43M 0.02% 867
2020
Q4
$2.75M Buy
43,616
+35,604
+444% +$2.21M 0.01% 1076
2020
Q3
$538K Sell
8,012
-2,208
-22% -$121K ﹤0.01% 1538
2020
Q2
$428K Buy
+10,220
New +$392K ﹤0.01% 1487

Other funds holding SILK

Man Group's SILK Position: Q3 2023 in Review

Man Group sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2023, closing a stake of 15,586 shares — an estimated $506K sold.

Man Group first reported a position in SILK in Q2 2020 and held it in 6 quarters. The position peaked at $3.51M in Q1 2021. 166 funds tracked by Wall St. Rank hold SILK as of Q3 2023.

  • Man Group reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Man Group sold 15,586 Silk Road Medical, Inc. Common Stock shares in Q3 2023, an estimated $506K.
  • Man Group first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2020 and held it in 6 quarters.
  • Man Group's Silk Road Medical, Inc. Common Stock position peaked at $3.51M in Q1 2021.
  • 166 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2023.

Based on Man Group's 13F filing for Q3 2023, filed 14 Nov 2023.